Champions Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BATTERY MANAGEMENT CORP. | 11/12/2024 | 2.42 M | $11.79 M | 0.00% | 17.81% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 1.71 M | $8.35 M | 0.00% | 12.61% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 11/08/2024 | 705,214 | $3.43 M | 3.01% | 5.19% |
| VANGUARD GROUP INC | 11/13/2024 | 307,002 | $1.50 M | 0.00% | 2.26% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 119,991 | $584,356 | -2.12% | 0.88% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 116,191 | $565,850 | 100.00% | 0.85% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 65,064 | $316,934 | 3.14% | 0.48% |
| MORGAN STANLEY | 11/14/2024 | 57,800 | $281,486 | 34.11% | 0.43% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 48,413 | $235,771 | -30.14% | 0.36% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 39,308 | $191,000 | 14.57% | 0.29% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 30,697 | $148,000 | 0.00% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 26,749 | $130,268 | 0.00% | 0.20% |
| STATE STREET CORP | 11/14/2024 | 26,553 | $129,313 | 0.00% | 0.20% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 25,308 | $123,250 | 0.14% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 15,000 | $73,050 | 100.00% | 0.11% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 10/28/2024 | 12,252 | $60,000 | 0.00% | 0.09% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 11/01/2024 | 12,000 | $58,440 | 0.00% | 0.09% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 10,763 | $52,416 | 100.00% | 0.08% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,553 | $12,433 | 100.00% | 0.02% |
| UBS GROUP AG | 11/14/2024 | 1,279 | $6,229 | 237.47% | 0.01% |
| JPMORGAN CHASE & CO | 12/26/2024 | 11 | $54 | 0.00% | 0.00% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
Champions Oncology, Inc.institutional Ownership - FAQ's
During the previous two years, 32 institutional investors and hedge funds held shares of Champions Oncology, Inc.. The most heavily invested institutionals were:
Battery Management Corp.: 2.42 M
NEA Management Company, LLC: 1.71 M
TOCQUEVILLE ASSET MANAGEMENT L.P.: 705,214
VANGUARD GROUP INC: 307,002
RENAISSANCE TECHNOLOGIES LLC: 119,991
BlackRock Funding, Inc. /DE: 116,191
42.55% of Champions Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.40 M shares in the last 24 months. This purchase volume represents approximately $69.50 M in transactions.